Skip to main content
Watch Insiders

Corporate insider profile

Jason P Rhodes Insider Trades

Latest reported as Director of Dyne Therapeutics, Inc. (DYN).

Purchase filings
0
Reported companies
1
Net open-market value
-$129,095,824.58
Latest transaction
Aug 14, 2026

Affiliated corporations

Reported company relationships

DYNLatest reported

Dyne Therapeutics, Inc.

Director

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 14, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale2,586,928$25.20$65,184,894
Jul 7, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale777,451$22.97$17,858,516
Jun 29, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale504,695$21.23$10,712,555
Jun 25, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale267,760$21.09$5,646,496
May 6, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale106,723$18.14$1,936,339
Apr 28, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale227,337$18.38$4,178,522
Apr 27, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale384,549$18.47$7,101,120
Apr 22, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale834,302$19.75$16,477,381